drugset / Trial / NCT05063994
Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is a randomized, double-blind, active-controlled, phase III study of Chronocort® compared with immediate-release hydrocortisone replacement therapy in participants aged 16 years and over with Congenital Adrenal Hyperplasia.
Timeline
- Start
- 2022-05-24
- Primary completion
- 2024-02-02
- Completion
- 2024-02-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydrocortisone | Other / unclassified | 15 mg | Oral |
| Comparator | Hydrocortisone | Other / unclassified | 20 mg | Oral |
| Comparator | Hydrocortisone | Other / unclassified | 25 mg | Oral |
| Comparator | Hydrocortisone | Other / unclassified | 30 mg | Oral |